newsfilter
← Latest News
Business Wire·

Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger

Highlights Board's Robust Strategic Review Process and Unanimous Determination that Carisma Merger Maximizes Value for Stockholders Urges Stockholders to Vote "FOR" Transaction Ahead of Special Meeting of Stockholders